AROMASIN (25MG) (50 TABLETS)

Irreversible Steroidal Aromatase Inactivator | Targeted Estrogen Control, Gynecomastia Prevention & Estrogen Rebound Protection

Overview:
Aromasin (Exemestane) is a potent, highly selective steroidal aromatase inactivator engineered to control systemic estrogen levels. Recognized as a “suicide inhibitor,” Exemestane permanently binds to and inactivates the aromatase enzyme, preventing the conversion of circulating androgens into estrogens (specifically estradiol). This eliminates the risk of estrogen rebound, controls subcutaneous water retention, and guards against gynecomastia during androgenic research cycles.

This product is supplied as a secure pack containing 50 oral tablets, with each tablet accurately dosed at 25mg of active Exemestane.

Unlike non-steroidal aromatase inhibitors (such as Anastrozole or Letrozole) that bind reversibly to the aromatase enzyme—allowing suppressed estrogen levels to spike once medication stops—Exemestane permanently destroys the enzyme. Body tissues must synthesize new aromatase enzymes, completely preventing post-cycle “estrogen rebound.”

Additionally, Aromasin possesses mild androgenic properties that support IGF-1 levels and cause a less negative impact on lipid profiles compared to non-steroidal alternatives. The 25mg tablet strength is ideal for flexible splitting (e.g., 12.5mg or 25mg protocol doses), and 50 tablets provides an extended supply for cycle management and post-protocol recovery phases.

• Irreversible “Suicide” Inhibition: Permanently deactivates aromatase enzymes, ensuring zero estrogen rebound after stopping administration.
• Gynecomastia & Water Retention Control: Prevents tissue swelling, breast tenderness, and fluid bloat by lowering serum estradiol (E2) levels by up to 85%.
• Preserves IGF-1 Levels: Unlike non-steroidal AIs that can lower circulating IGF-1, Exemestane maintains or slightly elevates natural IGF-1 production.
• Favorable Lipid Profile Impact: Less detrimental to HDL/LDL cholesterol balances than non-steroidal alternatives due to its structural androgenic core.
• Endogenous LH & FSH Stimulation: Acts as a powerful agent during post-protocol recovery by triggering natural gonadotropin release.

• Half-Life & Timing: Exemestane has an active terminal elimination half-life of approximately 24 hours.
• Dietary Take: Always take tablets with a fat-containing meal or snack (dietary fats increase oral bioavailability and absorption of Exemestane by up to 40%).
• Dose Calibration: Common protocol dosing ranges from 12.5mg every other day (EOD) to 25mg daily, depending on total aromatizing androgen load and blood work.
• Swallowing: Swallow whole with water. Do not chew or crush.

• Avoid Excessive Suppression: Estrogen is essential for joint lubrication, bone density, lipid regulation, and central nervous system health. Avoid crushing estradiol (E2) to zero.
• Blood Work Baseline: Periodically evaluate serum Estradiol (E2), total testosterone, and lipid panels to fine-tune dosage frequency.
• Hydration: Maintain consistent water intake throughout active protocols.